These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 6820915)
1. [Effects of protein calorie intake on immuno- and chemotherapy]. Akimoto M; Abe R; Kasai M Gan To Kagaku Ryoho; 1982 Aug; 9(8):1387-93. PubMed ID: 6820915 [TBL] [Abstract][Full Text] [Related]
2. [Modulation of the anti-tumor effect of BRM under various nutritional or endocrine conditions]. Akimoto M; Nishihira T; Kasai M Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1270-6. PubMed ID: 3729450 [TBL] [Abstract][Full Text] [Related]
3. [Modulation of anticancer effects of immunochemotherapeutic agents in various nutritional environments]. Akimoto M; Nishihira T; Mori S Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):827-33. PubMed ID: 3260467 [TBL] [Abstract][Full Text] [Related]
4. [Prevention of 5-FU induced toxicity in C3 H/HE mice with interferon or with interferon inducers (poly 1: C, OK-432, Lentinan)]. Akimoto M; Ueki H; Nakajima Y; Matano S; Ewasaki H; Abe R; Kasai M Gan To Kagaku Ryoho; 1984 Jul; 11(7):1462-7. PubMed ID: 6204597 [TBL] [Abstract][Full Text] [Related]
5. [The effect of an arginine-imbalanced diet on the growth of implanted MM-48 and MH-134 tumors in C3H/He mice]. Akimoto M; Nakajima Y; Iwasaki H; Matano S; Hirakawa H; Abe R; Kasai M Gan To Kagaku Ryoho; 1986 Feb; 13(2):330-6. PubMed ID: 2418792 [TBL] [Abstract][Full Text] [Related]
6. [Reduction of 5-FU toxicity with improved nutritional status in tumor bearing mice]. Akimoto M; Ohuchi N; Matano S; Hirakawa H; Abe M; Nishihira T; Mori S Gan To Kagaku Ryoho; 1989 Nov; 16(11):3609-13. PubMed ID: 2479340 [TBL] [Abstract][Full Text] [Related]
7. [Antitumor effect of polysaccharide lentinan on C3H/He mice bearing MH134 ascites hepatoma]. Moriyama M; Miwa H; Moriya N; Orita K Gan To Kagaku Ryoho; 1982 Jul; 9(6):1102-7. PubMed ID: 6820909 [TBL] [Abstract][Full Text] [Related]
8. [Correlation between the growth of transplantable tumors under protein deprivation and intratumoral amino acid concentration]. Akimoto M; Nakajima Y; Matano S; Iwasaki H; Nishihara T; Kasai M Gan No Rinsho; 1985 Jan; 31(1):73-7. PubMed ID: 3981804 [TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene-induced carcinogenesis. Suga T; Shiio T; Maeda YY; Chihara G Cancer Res; 1984 Nov; 44(11):5132-7. PubMed ID: 6488173 [TBL] [Abstract][Full Text] [Related]
10. [Metastatic behavior of footpad-inoculated tumors in mice and the impact of OK-432 per os administration]. Nakajima Y; Akimoto M; Kimura M; Iwasaki H; Matano S; Hirakawa H; Mori S Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1229-33. PubMed ID: 3579323 [TBL] [Abstract][Full Text] [Related]
11. [Effect of combined use of radiation and twice intratumor administration of OK-432 at one week intervals against a murine fibrosarcoma (NFSA)]. Mukai M; Ando K; Koike S Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):631-5. PubMed ID: 3355184 [TBL] [Abstract][Full Text] [Related]
12. [Role of the spleen in OK-432 immunotherapy and characterization of effector cells]. Yamagishi H; Naito K; Maeda Y; Kobayashi M; Kurioka H; Fujimori C; Tanaka T; Hashimoto I Gan To Kagaku Ryoho; 1983 Jul; 10(7):1670-8. PubMed ID: 6870309 [TBL] [Abstract][Full Text] [Related]
13. Effect of sequence of administration of methotrexate, leucovorin, and 5-fluorouracil on mammary tumor growth and survival in syngeneic C3H mice. Heppner GH; Calabresi P Cancer Res; 1977 Dec; 37(12):4580-3. PubMed ID: 303542 [TBL] [Abstract][Full Text] [Related]
14. Down-regulation of IL-10 enhances the efficacy of locoregional immunotherapy using OK-432 against malignant effusion. Hihara J; Yamaguchi Y; Minami K; Noma K; Toge T Anticancer Res; 1999; 19(2A):1077-84. PubMed ID: 10368657 [TBL] [Abstract][Full Text] [Related]
15. [Anti-cancer effects of BRMs associated with nutrition in cancer patients]. Nishihira T; Akimoto M; Mori S Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-3):1615-20. PubMed ID: 3382233 [TBL] [Abstract][Full Text] [Related]
16. Dietary lutein inhibits mouse mammary tumor growth by regulating angiogenesis and apoptosis. Chew BP; Brown CM; Park JS; Mixter PF Anticancer Res; 2003; 23(4):3333-9. PubMed ID: 12926072 [TBL] [Abstract][Full Text] [Related]
17. Effect of dietary astaxanthin at different stages of mammary tumor initiation in BALB/c mice. Nakao R; Nelson OL; Park JS; Mathison BD; Thompson PA; Chew BP Anticancer Res; 2010 Jun; 30(6):2171-5. PubMed ID: 20651366 [TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928 [TBL] [Abstract][Full Text] [Related]
19. [Combined use of lentinan with X-ray therapy in an experimental mouse tumor system (Part 2). Combined effect on the MM102 syngeneic tumor]. Shiio T; Ohishi K; Tsuchiya Y; Niitsu I; Hayashibara H; Yoshihama T; Moriyuki H Gan To Kagaku Ryoho; 1988 Mar; 15(3):475-9. PubMed ID: 3348633 [TBL] [Abstract][Full Text] [Related]
20. [Experimental study on the effectiveness of BRM in radiation therapy--OK-432 and cyclophosphamide]. Norimura T; Kunugita N; Dohi S; Mukae S; Tsuchiya T Gan No Rinsho; 1988 Oct; 34(13):1811-5. PubMed ID: 3199515 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]